Cryptococcal prostatitis in an immunocompromised patient with tocilizumab and glucocorticoid therapy: A case report
- 15 August 2024
- journal article
- case report
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 31 (1) , 102494
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Trends in the Incidence of Disseminated Cryptococcosis in Japan: A Nationwide Observational Study, 2015–2021Mycopathologia, 2024
- Microbe Profile: Cryptococcus neoformans species complexMicrobiology, 2020
- Fungal prostatitis due to endemic mycoses and Cryptococcus: A multicenter case seriesThe Prostate, 2020
- Disseminated cryptococcosis in a patient taking tocilizumab for Castleman's diseaseJournal of Infection and Chemotherapy, 2018
- Tocilizumab: A Review in Rheumatoid ArthritisDrugs, 2017
- Comprehensive overview of prostatitisBiomedicine & Pharmacotherapy, 2017
- Interleukin (IL-6) ImmunotherapyCold Spring Harbor Perspectives in Biology, 2017
- Cryptococcus: from environmental saprophyte to global pathogenNature Reviews Microbiology, 2015
- Primary cryptococcal prostatitis and correlation with serum prostate specific antigen in a renal transplant recipientJournal of Infection, 2005
- Fluconazole penetration into the prostatic fluid of patients with AIDS- associated cryptococcal meningitisJournal of Antimicrobial Chemotherapy, 1998